A supporter asks us to elaborate on projects other than allotopic expression (AE), that SRF has undertaken that are targeting mitochondrial dysfunction; and how they relate to the original strategy of allotopic expression?
A supporter asks about how the central MitoSENS strategy can be delivered to our cells.
Week Two of our 2022 End of Year Campaign features MitoSENS (Preventing Damage from Mitochondrial Mutations) – with a disease focus on Challenging Sarcopenia. Also featuring videos from Life Noggin, AMA with Dr. Amutha Boominathan and Michael Rae.
Part of: AmyloSENS ApoptoSENS GlycoSENS LysoSENS MitoSENS OncoSENS RepleniSENS Research Info Team Members Publications Photos Funding Research Info Team Members Publications Photos Funding Mitochondria perform and support several vital functions in a cell, and the alternate genome, mtDNA, plays a critical role in organelle maintenance. There is increasing evidence that mitochondrial function declines with age, …
Sign up to stay informed about the latest news and opportunities with SRF!
Use of this Web site constitutes acceptance of the Terms of Use and Privacy Policy.
© 2023 SENS Research Foundation – ALL RIGHTS RESERVED
